Literature DB >> 31706912

Parent testimonial: A caregiver whose son with inhibitors has been receiving emicizumab.

David Page1.   

Abstract

Emicizumab, grantted via compassionate access, has transformed the life of my son. Prior to receiving emicizumab, he was hospitalized and no therapies were effective in stopping his bleeding. Since the start of emicizuamb treatment, he has had no bleeds and has started doing many activities like a normal boy.
Copyright © 2019. Published by Elsevier Ltd.

Entities:  

Keywords:  Hemophilia

Mesh:

Substances:

Year:  2019        PMID: 31706912     DOI: 10.1016/j.transci.2019.08.004

Source DB:  PubMed          Journal:  Transfus Apher Sci        ISSN: 1473-0502            Impact factor:   1.764


  1 in total

1.  European principles of inhibitor management in patients with haemophilia: implications of new treatment options.

Authors:  C Hermans; P L F Giangrande; B O'Mahony; P de Kleijn; M Bedford; A Batorova; J Blatný; K Jansone
Journal:  Orphanet J Rare Dis       Date:  2020-08-24       Impact factor: 4.123

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.